Overcoming resistance to EGFR-TKI in NSCLC by simultaneously inhibition of anti-apoptotic proteins

被引：0
|
作者：
Weller, Sandra
Beigl, Tobias
Essmann, Frank
Harsch, Annika
Kopp, Hans-Georg
Ekstrom, Tom
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6484
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6484
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EGFR-TKI resistance in NSCLC patients: mechanisms and strategies
    Lin, Yuxin
    Wang, Xian
    Jin, Hongchuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2014, 4 (05): : 411 - 435
  • [2] Overcoming EGFR-TKI resistance in EGFR-mutated lung cancer
    Gardizi, M.
    Scheffler, M.
    Bos, M.
    Geist, T.
    Heukamp, L.
    Nogova, L.
    Toepelt, K.
    Fernandez-Cuesta, L.
    Culmann, H.
    Kaminsky, B.
    Panse, J.
    Becker, C.
    Mattonet, C.
    Serke, M.
    Schmitz, S.
    Schnell, R.
    Galetke, W.
    Hekmat, K.
    Buettner, R.
    Wolf, J.
    ONKOLOGIE, 2013, 36 : 30 - 30
  • [3] THERAPEUTIC STRATEGIES FOR OVERCOMING RESISTANCE TO EGFR-TKI AND ALK-TKI BY INHIBITION OF Hsp90 OR HDAC
    Takeuchi, Shinji
    Yano, Seiji
    ANNALS OF ONCOLOGY, 2014, 25
  • [4] The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
    Lu, S.
    Wang, Q.
    Zhang, G.
    Dong, X.
    Yang, C.
    Song, Y.
    Chang, G.
    Lu, Y.
    Pan, H.
    Chiu, C.
    Wang, Z.
    Feng, J.
    Zhou, J.
    Xu, X.
    Guo, R.
    Chen, J.
    Yang, H.
    Chen, Y.
    Yu, Z.
    Shiah, H.
    Wang, C.
    Yang, N.
    Fang, J.
    Wang, P.
    Wang, K.
    Hu, Y.
    He, J.
    Wang, Z.
    Shi, J.
    Chen, S.
    Cheng, Y.
    Su, W.
    Hsia, T.
    Cui, J.
    Sun, Y.
    Yang, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S208 - S209
  • [5] Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC
    Kim, Dong Min
    Kim, Mi Jin
    Moon, Jai-Hee
    Lee, Eun Young
    Hong, Jun Ki
    Lee, Seul
    Koh, Dong-In
    Ryu, Yae Seong
    Kim, Seung Mi
    Jung, Soo-A
    Shin, Jae-Sik
    Kim, Joseph
    Park, Yoon Sun
    Hong, Seung-Woo
    Lee, So Hee
    Jung, Joonyee
    Park, Sang Soo
    Kim, Do Yeon
    Kim, Eun Ho
    Jeong, Hong-Rae
    Gong, Ji Hee
    Kim, Jieun
    Kim, Seung Chan
    Yu, Ha Na
    Ki, So Young
    Kim, Tae Won
    Jin, Dong-Hoon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 527 (01) : 305 - 310
  • [6] Inhibition of CAD, an enzyme of de novo pyrimidine synthesis, to overcome EGFR-TKI resistance in NSCLC
    Zanjani, Leili Saeednejad
    Zhao, Lei
    Wang, Shaomin
    Federoff, Margot
    Sun, Xin
    He, Jun
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells
    Kurihara, E.
    Shien, K.
    Torigoe, H.
    Takahashi, Y.
    Ogoshi, Y.
    Yoshioka, T.
    Namba, K.
    Sato, H.
    Yamamoto, H.
    Soh, J.
    Toyooka, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S586 - S587
  • [8] EGFR-TKI FOR EGFR MUTATED NSCLC: NEW EVIDENCE
    Okamoto, I.
    ANNALS OF ONCOLOGY, 2010, 21 : 40 - 40
  • [9] DISCOVERY THE NOVEL COMPOUND FOR OVERCOMING EGFR-TKI RESISTANCE IN LUNG ADENOCARCINOMA
    Huang, Kuo-Yen
    Lin, Chung-Chih
    Yang, Shuenn-Chen
    Yang, Pan-Chyr
    RESPIROLOGY, 2018, 23 : 176 - 176
  • [10] THE CLINICAL CONSIDERATION FOR MOLECULAR MECHANISM UNDERLYING EGFR-TKI RESISTANCE IN NSCLC
    Liao, Mei-Lin
    ANNALS OF ONCOLOGY, 2014, 25
12345